Evidence map›Paper›PMID 40488463›Full record

ArticleMicrobiology spectrum2025

Cycloserine resistance among drug-resistant tuberculosis cases in Taiwan.

Sheng-Han Wu, Hsin-Yi Liu, Kuang-Hung Liu, Hseuh-Chien Hsiao, Ruwen Jou

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sheng-Han Wu *Tuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.
Hsin-Yi Liu *Tuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.
Kuang-Hung LiuTuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.ORCID 0000-0001-5537-3005
Hseuh-Chien HsiaoTuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.
Ruwen JouTuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.ORCID 0000-0002-9378-6801

Funding

MOHW | Taiwan Centers for Disease Control (TCDC) MOHW109-CDC-C-315-114403,MOHW110-CDC-C-315-11440,MOHW111-CDC-C- 315-124305,MOHW112-CDC-C-315-134305
6 · The paper itself

Abstract

Cycloserine (CS) is a widely used drug for drug-resistant tuberculosis (DR-TB) treatment. The World Health Organization (WHO) recently suggested a critical concentration (CC) for CS using the MGIT 960 system (MGIT). To strengthen our DR-TB management program, we performed CS resistance analyses to provide comprehensive drug susceptibility testing (DST). This retrospective study included

Indexed as

Antitubercular AgentsCycloserineMycobacterium tuberculosisTuberculosis, Multidrug-ResistantBacterial ProteinsDrug Resistance, Multiple, BacterialGenotypeHumansMicrobial Sensitivity TestsMutationRetrospective StudiesTaiwanWhole Genome SequencingAntitubercular AgentsBacterial ProteinsCycloserinecritical concentrationcycloserinedrug resistancedrug susceptibility testingMycobacterium tuberculosistuberculosis

Identifiers

PMID40488463
PMCPMC12211041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.